Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE: 603229)
Health Care · Pharmaceuticals · CN
CN¥8.10
-3.23% today · -33.9% 1Y
Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE: 603229) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $994.18M and employs 1,328 people.
Over the last twelve months the share price has lost 33.9%, trading between 7.15 and 12.51.
Tweenvest scores Zhejiang Ausun Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 44/100, growth 12/100, dividend 18/100. Its strongest factor is quality.
603229 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $994.18M
- Revenue (TTM)
- $115.23M
- P/E
- 60.33
- EPS
- 0.13
- Dividend yield
- 0.79%
- Beta (5Y)
- -0.18
- 52-week high
- CN¥12.51
- 52-week low
- CN¥7.15
- Avg volume (3M)
- —
- Shares outstanding
- 825.10M
- Employees
- 1,328
- Next earnings
- —
About Zhejiang Ausun Pharmaceutical Co., Ltd.
Established in 2010 and headquartered in Linhai, China, Zhejiang Ausun Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of unique active pharmaceutical ingredients (APIs) and various intermediate compounds for drug synthesis. Its comprehensive portfolio includes fluorine-based compounds, prostaglandins, and anti-infectives, in addition to critical oncology therapeutics. The company also provides medications targeting liver, respiratory, cardiovascular, and cerebrovascular conditions, as well as central nervous system (CNS) disorders. Furthermore, Zhejiang Ausun Pharmaceutical is involved in contract processing services and continuous scientific research and development initiatives.
- ISIN
- CNE100002XK2
- Founded
- 2010
- Listed since
- May 9, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.